All posts by: Michael Zand

About Michael Zand

CRISPR patent “case of the year” hearing is a must-watch – and not just for the life sciences – IAM (blog)

Continue reading

2018-04-30 NEWS

IAM (blog)

CRISPR patent “case of the year” hearing is a must-watch – and not just for the life sciences
IAM (blog)
With news of the US Supreme Court’s recent Oil States decision and the UK’s ratification of the Unified Patent Court Agreement capturing the headlines in recent days, patent professionals might be forgiven for allowing a crucial CRISPR-Cas9 dispute to

Continue reading

2018-04-30 NEWS

Animal Pharm

Panion begins gene therapy safety study in dogs
Animal Pharm
Swedish firm Panion Animal Health has started a safety study for its canine gene therapy candidate at the University of Copenhagen in Denmark. Already a subscriber? Please sign in below to continue reading. Sign In. Thanks, we’ve sent a link to reset